1GUNDOGDU F, BOZKURD E, KIZILTUNC A, et al. The Effect of beta-blocker (carvedilol) therapy on n-terminal pro-brain natriuretic peptide levels and echocardiographic findings in patients with congestive heart failure[J]. Echocardiography, 2007, 24 (2): 113-117.
2PACKER M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure [J]. J Am Coll Cardiol, 1992, 20 (1): 248-254.
3MASSIE B M.15 years of heart-failure trials: what have we learned[J]? Lancet, 1998, 352 (1): 29-33.
4MORO C, BERLAN M. Cardiovascular and metabolic effects of natriuretic peptides[J]. Fundam Clin Pharmacol, 2006, 20 (1): 41-49.
5TROUGHTON R W, RICHARDS M. β-type natriuretic peptides: applications for heart failure management in 2005 [J]. Intern Med J, 2005, 35 (7): 377-379.
6MIR T S, MAROHN S, LAER S, et al.Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure[J]. Pediatrics,2002, 110 (6) : E76.
7BAL, THIERRY S, BROCAS E, et al. β-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress [J]. Acta Anaesthesiol Scand, 2006, 50 (3): 340-347.
8JANUZZI J L, VAN KIMMENADE R V, LAINCHBURY J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients[J]. Eur Heart J, 2006, 27(3): 330-337.
9CHEN A A, WOOD M J, KRAUSER DG, et al. NT- proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the proBNP investigation of dyspnoea in the emergency department (PRIDE) echocardiographic substudy european[J]. Eur Heart J, 2006, 27 (7): 839-845.
10KIM S W, PARK S W, LIM S H, et al. Amount of left ventricular hypertrophy determines the plasma N-terminal probrain natriuretic peptide level in patients with hypertrophic cardiomyopathy and normal left ventricular ejection fraction [J]. Clin Cardiol, 2006, 29 (4): 155-160.